Trials / Completed
CompletedNCT03859804
Comparison of Pain Levels in Fusion Prostate Biopsy and Standard TRUS-Guided Biopsy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 252 (actual)
- Sponsor
- TC Erciyes University · Academic / Other
- Sex
- Male
- Age
- 50 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study was to compare the pain levels in transrectal ultrasound (TRUS)-guided standard 12-core prostate biopsy (SPB) and multiparametric prostate magnetic resonance imaging (MpMRI)-guided fusion prostate biopsy (FPB).
Detailed description
The study included patients that underwent prostate biopsy under local anesthesia (intrarectal 2% lidocaine gel + periprostatic nerve block) due to suspected prostate cancer. Patients detected with a Prostate Imaging Reporting and Data System score (PIRADS) ≥3 lesion on MpMRI underwent MpMRI-guided FPB (Group I) and the patients who had no suspected lesions or had a PI-RADS \<3 lesion on MpMRI underwent TRUS-guided SPB (Group II). Pain assessment was performed using Visual Analog Scale (VAS) 5 min after the procedure. Following the procedure, the patients were asked to indicate the most painful biopsy step among the three steps (1: insertion of the probe into the rectum, 2: probe manipulation, 3: the piercing of the biopsy needle).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Standard transrectal 12 core biopsy | TRUS-guided SPB was performed by obtaining 12 core samples in each patient. 6 cores from left and right. the cores labeled as, apex, mid, base, apex far lateral, mid far lateral and base far lateral |
| PROCEDURE | MRI- US fusion prostate biopsy (FPB) | FPB was performed by obtaining 10-12 core samples in each patient, followed by the acquisition of 2-4 core samples for each suspected lesion detected on MpMRI (combined biopsy) |
Timeline
- Start date
- 2016-12-01
- Primary completion
- 2019-01-31
- Completion
- 2019-02-01
- First posted
- 2019-03-01
- Last updated
- 2019-03-01
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT03859804. Inclusion in this directory is not an endorsement.